The eight-year long-term follow-up on the effectiveness of the quadrivalent human papillomavirus vaccine in Chinese women 20-45 years of age

The quadrivalent human papillomavirus (4vHPV) vaccine has shown confirmative effectiveness in preventing HPV-related diseases among women and men around the globe. The phase III, randomized, double-blind efficacy study (Base study, NCT00834106) conducted in China showed 100% efficacy against HPV 16/...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chao, Zhao, Yun, Li, Jingran, Li, Mingzhu, Su, Yanyan, Mi, Xin, La Tu, Su Yi, Shen, Danhua, Ren, Lihua, Li, Yanyan, Wang, Linhong, Wei, Lihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
HPV – Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225595/
https://www.ncbi.nlm.nih.gov/pubmed/35358015
http://dx.doi.org/10.1080/21645515.2022.2052700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225595/
https://www.ncbi.nlm.nih.gov/pubmed/35358015
http://dx.doi.org/10.1080/21645515.2022.2052700

Ejemplares similares